Kent Lin

机构：Washington University in St. Louis · ORCID：0000-0002-2521-1328

发表论文 10 篇 · 总被引 623 次 · h-index 5

代表论文

• TREM2 drives microglia response to amyloid-β via SYK-dependent and -independent pathways (2022 · Cell · 被引 479)
• Targeting tauopathy with engineered tau-degrading intrabodies (2019 · Molecular Neurodegeneration · 被引 63)
• Antibody-mediated targeting of human microglial leukocyte Ig-like receptor B4 attenuates amyloid pathology in a mouse model (2024 · Science Translational Medicine · 被引 45)
• Loss of ATG7 in microglia impairs UPR, triggers ferroptosis, and weakens amyloid pathology control (2025 · The Journal of Experimental Medicine · 被引 16)
• Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy (2026 · Science · 被引 15)
• Reliability of 200mm E-mode GaN-on-Si Power HEMTs (2020 · 被引 5)